FABP4 and metabolic disease: A further mechanistic understanding of the actions of FABP4 and FBAP5 may enable a promising approach of regenerative medicine using ADSC for transforming undifferentiated cells into specific cells as well as the development of new therapeutic strategies for cardiovascular and metabolic diseases, such as neutralization of FABP4 and/or blockade of the FABP4 receptor, if any.